![]() | PDF (452kB) - Repository staff only |
- DOI to cite this document:
- 10.5283/epub.1234
Abstract
The epidermal growth factor receptor (EGFR, ErbB1) is frequently dysregulated in a variety of solid human tumors, including malignant glioma. EGFR expression has been associated with disease progression, resistance to standard therapies and poor survival. The application of small interfering RNAs (siRNAs) has become an effective and highly specific tool to modulate gene expression, and a wide ...

Owner only: item control page